insulin glargine (Lantus)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

Better Blood Sugar Balance

Long term use of insulin glargine can lead to thickening of fat tissues at the injection site.

Severe allergic reactions are:

Individuals should contact a healthcare professional if they experience any of the above reactions.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Insulin glargine is available as 100 units/ml. Insulin glargine is supplied in 10 ml vials, 3 ml SoloStar injectable pens, and a 3 ml cartridge system. Insulin glargine is given only by subcutaneous injection.

STORAGE:

  • Unopened vials, SoloStar pens, and cartridge systems should be refrigerated between 2 C and 8 C (36 F and 46 F).
  • Unopened vials, SoloStar pens, and cartridge systems, if refrigerated, are good until the expiration dates.
  • Unopened vials, SoloStar pens, and cartridge systems, stored at room temperature, are good for 28 days.
  • Opened vials and cartridge systems can be refrigerated or stored at room temperature below 30 C (86 F).
  • Cartridge systems inserted into the insulin delivery device and SoloStar pens should be stored only at room temperature below 30 C (86 F).
  • Opened vials, SoloStar pens, and cartridge systems are good for 28 days.

DOSING:

Type 1 diabetes: For patients 6 years of age and older, patients' total daily insulin requirement must be calculated individually. In the beginning, insulin glargine should be one-third of the requirement, given subcutaneously once daily. The maintenance dose is determined based on individual response, given once daily. Insulin glargine must be used in combination with rapid or short acting insulin.

Type 2 diabetes: Start with 10 units of insulin glargine subcutaneously once daily at the same time every day. The maintenance dose is determined based on individual response.

Safe and effective use of insulin glargine is not established for children with type 2 diabetes nor in patients younger than 6 years of age with type 1 diabetes.

DRUG INTERACTIONS: There are many drugs that do not directly interfere with insulin glargine, but they may affect glucose breakdown in the body. This necessitates adjustments of insulin glargine doses.

Medically Reviewed by a Doctor on 12/23/2014

Quick GuideType 2 Diabetes Symptoms, Warning Signs, and Management

Type 2 Diabetes Symptoms, Warning Signs, and Management
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Diabetes Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors